An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy

Muscle and Nerve

Volumn 40, Issue 4, 2009, Pages 652-656

  Elsheikh, Bakri ^a   Prior, Thomas ^a   Zhang, Xiaoli ^a   Miller, Robert ^b   Kolb, Stephen J ^a   Moore, D A N ^b   Bradley, Walter ^c   Barohn, Richard ^d   Bryan, Wilson ^e   Gelinas, Deborah ^f   Iannaccone, Susan ^g   Leshner, Robert ^h   Mendell, Jerry R ^a,i   Mendoza, Michelle ^b   Russman, Barry ^j   Smith, Stephen ^k   King, Wendy ^a   Kissel, John T ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e Biologics Consulting Group Inc   (United States)

^f Nashoba Valley Healthcare Group   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^j SHRINERS HOSPITAL FOR CHILDREN   (United States)

^k HENNEPIN COUNTY MEDICAL CENTER   (United States)

more..

Author keywords

Motor neuron; MVIC; SMA; SMAFRS; SMN2 copy number

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE; HUMAN; LUNG FUNCTION TEST; MALE; MUSCLE STRENGTH; ONSET AGE; PRIORITY JOURNAL; SMN2 GENE; SPINAL MUSCULAR ATROPHY;

ACTIVITIES OF DAILY LIVING; ADULT; AMINES; COHORT STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DISABILITY EVALUATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCULAR ATROPHY, SPINAL; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 70349338716     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21350     Document Type: Article

References (13)

1. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of SMA. Am J Hum Genet 2002;70:358-368. (Pubitemid 34112291)
2. Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4:20-26. (Pubitemid 44698460)
3. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNt and SMNc gene copy number. Am J Hum Genet 1997;60:1411-1422. (Pubitemid 27258073)
4. Miller RG, Moore DH, Dronsky V, Bradley W, Barohn R, Bryan TW, et al. A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci 2001;191:127-131. (Pubitemid 33035905)
5. Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 2000;9:333-339. (Pubitemid 30098725)
6. Oprea GE, Kröber S, McWhorter ML, Rossoll W, Muller S, Krawczak M, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008;320:524-527. (Pubitemid 351590664)
7. Ottenbacher KJ, Taylor ET, Msall ME, Braun S, Granger CV, Lyons N, et al. The stability and equivalence reliability of the functional independence measure for children (Wee-FIM). Dev Med Child Neurol 1996;38:907-916. (Pubitemid 26340849)
8. Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ. Homozygous SMN1 deletion in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet 2004;130A:307-310.
9. Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number and function. Ann Neurol 2005;57:704-712.
10. The ALS CNTF Treatment Study (ACTS) phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
11. Tiziano FD, Bertini E, Messina S, Angelozzi C, Pane M, D'Amico A, et al. The Hammersmith functional score correlates with the SMN2 copy number: a multicenteric study. Neuromuscul Dis 2007;17:400-403. (Pubitemid 46679240)
12. Wirth B, Brichta L, Schrank B, Lochmüller H, Blick S, Baasner A, et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Gen 2006;119:422-428.
13. Zerres K, Wirth B, Rundik-Schöneborn S. Spinal muscular atrophy - clinical and genetic correlations. Neuromuscul Dis 1997;7:202-207. (Pubitemid 27243812)